Literature DB >> 31796913

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease.

Linde M Morsink1,2, Evandro D Bezerra3,4, Megan Othus5, Brent L Wood6, Min Fang1,7, Brenda M Sandmaier1,8, Marco B Mielcarek1,8, H Joachim Deeg1,8, Gary Schoch1, Frederick R Appelbaum1,8, Roland B Walter9,10,11,12.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31796913      PMCID： PMC7266710          DOI： 10.1038/s41375-019-0671-x

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.

Authors:  Gabrielle Paras; Linde M Morsink; Megan Othus; Filippo Milano; Brenda M Sandmaier; Lucas C Zarling; Raffaele Palmieri; Gary Schoch; Chris Davis; Marie Bleakley; Mary E D Flowers; H Joachim Deeg; Frederick R Appelbaum; Rainer Storb; Roland B Walter
Journal:  Blood       Date:  2022-03-17       Impact factor: 22.113

2.  Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Authors:  Linde M Morsink; Brenda M Sandmaier; Megan Othus; Raffaele Palmieri; Noa Granot; Evandro D Bezerra; Brent L Wood; Marco Mielcarek; Gary Schoch; Chris Davis; Mary E D Flowers; H Joachim Deeg; Frederick R Appelbaum; Rainer Storb; Roland B Walter
Journal:  Cancers (Basel)       Date:  2020-08-19       Impact factor: 6.639

3.  Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.

Authors:  Lucas C Zarling; Megan Othus; Brenda M Sandmaier; Filippo Milano; Gary Schoch; Chris Davis; Marie Bleakley; H Joachim Deeg; Frederick R Appelbaum; Rainer Storb; Roland B Walter
Journal:  Leukemia       Date:  2022-04-19       Impact factor: 12.883

4.  Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia.

Authors:  Tali Azenkot; Brian A Jonas
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

5.  Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML.

Authors:  Linde M Morsink; Megan Othus; Evandro D Bezerra; Brent L Wood; Min Fang; Brenda M Sandmaier; Marco Mielcarek; Gary Schoch; Rainer Storb; H Joachim Deeg; Frederick R Appelbaum; Roland B Walter
Journal:  Leukemia       Date:  2020-01-23       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.